EMD Millipore appoints Robert Yates president
This article was originally published in Scrip
EMD Millipore, the life science division of Merck KGaA, has appointed Robert Yates president reporting to Bernd Reckmann, one of Merck KGaA's board members responsible for the chemicals business sector. Mr Yates joins EMD Millipore from the diagnostics division of Roche where he led the life science business in Germany and served as a member of the Diagnostics Executive Committee.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.